This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Strategic M&A Analysis
Bourgeois, L. J. III; Hoeber, HenningTechnical Note DARDEN-S-0224-EStrategyThis note deals with the issues of strategy, the first common source of acquisition failure. An appropriate master plan that links strategy and integration is a critical requirement for this interplay and ensures that the target will improve the acquirer’s overall competitive abilities.Starting at €8.20
-
Twenty Questions for Every M&A: Improving Postmerger Integration Performance
Bourgeois, L. J. III; Harvey, AllenTechnical Note DARDEN-S-0226-EStrategyThis note is used in Darden's Postmerger Integration elective. The authors present a guide to help managers prepare for integration challenges and allocate integration resources more efficiently. Although simple at first glance, addressing 20 yes-or-no questions can lead to fruitful in-depth conversations that provide a sound foundation for successful PMI planning and execution. By answering these questions in open dialogue, PMI managers and seni...Starting at €8.20
-
Roma Victor: Europe's First Serial Acquirer
Bourgeois, L. J. III; Hoeber, HenningCase DARDEN-BP-0551-ECorporate GovernanceBesides adopting the tactics and types of arms and armor effectively used by its adversities, the Romans also incorporated superior intangibles such as tactical knowledge of their enemies. This case is used in Darden's "Post-Merger Acquisition" course elective to draw parallels to M & A strategies used by corporations today.Starting at €8.20
-
Building the New Bosco-Zeta Pharma (B)
Bourgeois, L. J. III; Hammaker, Paul M.; Powers, John; Mathur, Sudeep; Bose, NandiniCase DARDEN-BP-0536-ECorporate GovernanceThe Bosco chairman realizes that Bosco and Zeta have different work cultures and to make the integration a success, it was imperative to create a new unique identity for the new company Bosco-Zeta Pharma. He decides that the goal is to retain the best elements of the existing social capital from the two separate organizations while improving the new company’s responsiveness to customers, competitors, and the market environment. He requests that a...Starting at €5.74
-
Building the New Bosco-Zeta Pharma (A)
Bourgeois, L. J. III; Hammaker, Paul M.; Bose, Nandini; Goswami, Yogesh; Mathur, Sudeep; Powers, JohnCase DARDEN-BP-0525-ECorporate GovernanceAfter Bosco Pharmaceutical’s acquisition of Zeta AG, the Bosco chairman is unsure whether to merge the two firms using only internal resources or accept the help of Deloitte Consulting. Deloitte advocates an overhaul of Bosco’s organizational structure to accommodate Zeta, a company one-fifth Bosco’s size. The chairman is uncertain whether to adopt Zeta’s worldwide product structure or whether Zeta should be required to conform to Bosco’s more ge...Starting at €8.20
-
Advanced Leadership Field Perspectives: Shanghai
Kirby, William C.; Zendell, Erica MCase HBS-315107-EStarting at €8.20
-
The China Entrepreneurs Forum, Teaching Note
Kirby, William C.; Zendell, Erica MTeaching Note HBS-314132-ELeadership and People ManagementTeaching Note for 312095.Starting at €0.00
-
Kunshan, Incorporated: The Making of China's Richest Town, Teaching Note
Kirby, William C.; Zendell, Erica MTeaching Note HBS-314131-EEconomicsTeaching Note for 314131.Starting at €0.00
-
Taikang Insurance: Standing Out in China's Crowded Insurance Market, Teaching Note
Kirby, William C.; Zendell, Erica MTeaching Note HBS-314133-ETeaching Note for 312109.Starting at €0.00
-
Jiamei Dental: Private Health Care in China, Teaching Note
Kirby, William C.; Zendell, Erica MTeaching Note HBS-314136-ETeaching Note for 910404.Starting at €0.00